WERN Q1 2026 Earnings EPS Surges Past Estimates Marking a Strong Turnaround OXLCN Q4 2025 Earnings Preferred Stock Reports Slight EPS Miss Amid Steady Portfolio Performance CRGO Q1 2026 Earnings EPS Misses Estimates as Stock Declines on WiderThanExpected Loss Ernexa Therapeutics ERNA Q3 2023 Earnings Deepening Losses and ClinicalPhase Uncertainty Weigh on Shares ASTC Q1 2024 Earnings Loss per Share of 179 Reflects Continued PreRevenue Investment Phase Teva Q1 2026 Earnings Strong EPS Beat on Cost Discipline Shares Edge Higher